Difficulty: Medium
Average Score: 70%
Practice
The following drugs do not readily cross to the CNS
Correct answer
D
Rationale
In pharmacology, understanding which drugs can readily cross the blood-brain barrier (BBB) to reach the central nervous system (CNS) is crucial for predicting their effects. Neostigmine, the correct answer (D), is a quaternary ammonium compound that does not easily cross the BBB due to its charged nature. This limited CNS penetration is advantageous when neostigmine is used to treat conditions like myasthenia gravis, as it acts peripherally to inhibit acetylcholinesterase.
Dopamine (A) and levodopa (B) are both neurotransmitters that can cross the BBB. Dopamine is involved in various CNS functions like movement and mood regulation, while levodopa is a precursor to dopamine used in Parkinson's disease to increase central dopamine levels.
Atropine (C) is a tertiary ammonium compound that can cross the BBB to some extent, leading to its CNS effects like sedation and confusion. This differentiation highlights the importance of drug properties in determining their ability to reach the CNS and exert their therapeutic or side effects.
In an educational context, this question emphasizes the significance of understanding drug pharmacokinetics and the BBB in pharmacology. It underscores the need for healthcare professionals to consider a drug's ability to penetrate the CNS when selecting treatments and predicting their efficacy and potential adverse effects.
Dopamine (A) and levodopa (B) are both neurotransmitters that can cross the BBB. Dopamine is involved in various CNS functions like movement and mood regulation, while levodopa is a precursor to dopamine used in Parkinson's disease to increase central dopamine levels.
Atropine (C) is a tertiary ammonium compound that can cross the BBB to some extent, leading to its CNS effects like sedation and confusion. This differentiation highlights the importance of drug properties in determining their ability to reach the CNS and exert their therapeutic or side effects.
In an educational context, this question emphasizes the significance of understanding drug pharmacokinetics and the BBB in pharmacology. It underscores the need for healthcare professionals to consider a drug's ability to penetrate the CNS when selecting treatments and predicting their efficacy and potential adverse effects.